1620 Investment Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
1620 Investment Advisors, Inc.
- $125 Million
- Q1 2025
A detailed history of 1620 Investment Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 2,277 shares of AMPH stock, worth $58,109. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,277
Previous 2,288
0.48%
Holding current value
$58,109
Previous $84,000
21.43%
% of portfolio
0.05%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$152 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.8 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$56.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.6 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.25B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...